Skip to main content
. Author manuscript; available in PMC: 2018 May 3.
Published in final edited form as: Antivir Ther. 2017;22(8):659–668. doi: 10.3851/IMP3155

Table 3. Factors associated with CD4:CD8 ratio greater than 0.2 at baseline.

OR 95 % CI p-value p-overall* OR 95 % p-value p-overall
AHOD

TAHOD 0.309 (0.254, 0.377) <0.001 0.493 (0.396, 0.614) <0.001

Age per 10 years 0.956 (0.893, 1.024) 0.202

Female 1.075 (0.897, 1.289) 0.433

MSM**
Heterosexual 0.414 (0.355, 0.481) <0.001 <0.001 0.580 (0.488, 0.689) <0.001 <0.001
IDU 0.559 (0.373, 0.837) 0.005 0.614 (0.401, 0.941) 0.025
Other/missing 0.571 (0.440, 0.740) <0.001 0.734 (0.556, 0.968) 0.029

Never HBV
HBV positive ever 0.898 (0.667, 1.210) 0.480 0.734
Missing 0.964 (0.822, 1.132) 0.656

Never HCV
HCV positive ever 1.265 (0.945, 1.693) 0.114 0.021
Missing 0.847 (0.720, 0.995) 0.043

No Prior AIDS
Prior AIDS 0.302 (0.259, 0.352) <0.001 0.361 (0.306, 0.426) <0.001
*

P-values reported for test of homogeneity in nominal covariates and test for trend in ordinal covariates

**

MSM: men who have sex with men; IDU: injection drug users